cloud based digital signage singapore

Wellteq Signs Global Agreement to Supply Digital Wellness Services to Fortune 500 US Bank Northern Trust Corporation

  • Wellteq (CSE.WTEQ) (OTCQB.WTEQF) has signed a 5-year global Master Services Agreement (MSA) to supply digital wellness services to Northern Trust Corporation (NASDAQ.NTRS) employees.
  • Northern Trust, a Fortune 500 company and leading financial services provider with more than 20,000 employees globally, is set to initiate delivery of the WellteQ Digital Health platform to employees within the Asia-Pacific region.
  • The first stage of deployment commences in Q3 2021 for employees in Singapore, Hong Kong, Australia, and the Philippines.

WellteQ Digital Health Inc. (CSE.WTEQ) (OTCQB.WTEQF) (the "Company" or "Wellteq") is pleased to announce the Company has signed a global Master Services Agreement for 5 years with Northern Trust Corporation, a leading provider of wealth management, asset servicing, asset management and banking to corporations, institutions, families, and individuals.

Companies invest into preventative or corrective health services for their workforces to improve employee health, workplace culture and team engagement and to reduce employee related costs such as absenteeism and preventable healthcare risk, preventable care utilization, and related care expenditures. A 2010 study published by Harvard University: Health Affairs estimated that, for every dollar spent on corporate wellness programs, medical costs fell by approximately $3.27 and absenteeism costs fell by about $2.73 for every dollar spent. 1 With such quantifiable benefits, the industry is projected to grow to over US $90 billion annually by the end of 2026. 2

Through its smartphone application, Wellteq offers personalized wellness, risk reduction, illness prevention and digital coaching capabilities to employees in over 30 countries and 12 languages. Wellteq's capabilities are seamlessly integrated with wearables, such as Garmin (NASDAQ.GRMN), Apple Watch (NASDAQ.AAPL) and Fitbit (NASDAQ.GOOGL), and with rewards, incentives and telemedicine partners.

As a banking institution with offices across the United States and 23 locations in Canada, Europe, the Middle East, and the Asia-Pacific region, Northern Trust has recognized the importance of offering localized employee wellness solutions to their regional teams. The first wave of the Wellteq deployment offers Wellteq's digital health platform to Northern Trust's Asia Pacific employees in Singapore, Hong Kong, Australia and the Philippines commencing in Q3, 2021.

Wellteq CEO Scott Montgomery stated, "Wellbeing is more essential than ever. While employees try to cope with drastic and rapid workplace changes and professional stresses, employers need to find new tools to help support employees. A recent survey from the Centers for Disease Control and Prevention found that 41% of all U.S. adults are struggling with mental health 3 stemming from the COVID-19 pandemic. Wellteq's behaviour change support programs offer credible health information and digital coaching across sleep, activity, mindset and nutritional habits and we're working with forward-thinking organizations like Northern Trust that genuinely care to help their teams survive and thrive in this new normal."

"We are deeply committed in supporting our employees and encourage holistic wellbeing," said Angelo Calvitto, Head of Asia Pacific, Northern Trust. "Wellteq complements the extensive suite of benefits and resources we provide our employees and will help bring them the most relevant resources to boost their physical, emotional, and financial health while at work and at home."

About Wellteq

Wellteq Digital Health Inc. is a leading provider of personalized digital health and wellness solutions across the Continuum of Care. To learn more, visit .

About Northern Trust

Northern Trust Corporation (NASDAQ.NTRS) is a leading provider of wealth management, asset servicing, asset management and banking to corporations, institutions, affluent families and individuals. Founded in Chicago in 1889, Northern Trust has a global presence with offices in 22 U.S. states and Washington, D.C., and across 23 locations in Canada, Europe, the Middle East and the Asia-Pacific region. As of March 31, 2021, Northern Trust had assets under custody/administration of US$14.8 trillion, and assets under management of US$1.4 trillion. For more than 130 years, Northern Trust has earned distinction as an industry leader for exceptional service, financial expertise, integrity and innovation. Please visit our website or follow us on Twitter . Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S. Please read our global and regulatory information .

Cautionary Note Regarding Forward-Looking Statements:

This news release contains information or statements that constitute "forward-looking statements." These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements, or developments to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. These statements that are not historical facts and are generally, but not always, identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

These statements made in this news release are based on management's assumptions and analysis and other factors that may be drawn upon by management to form conclusions and make forecasts or projections, including management's experience and assessments of historical trends, current conditions and expected future developments. Although management believes that these assumptions, analyses and assessments are reasonable at the time the statements contained in this news release are made, actual results may differ materially from those projected in any forward-looking statements.

The forward-looking information contained in this news release represents the expectations of Wellteq as of the date of this news release and, accordingly, is subject to change after such date.

The CSE has neither approved nor disapproved the contents of this news release.

1 Harvard University: Health Affairs. "Workplace Wellness Programs Can Generate Savings." February 2010.

2 MarketsandMarkets Research Private Ltd. "Corporate Wellness Solutions Market Worth $94.6 billion by 2026 – Exclusive Report by MarketsandMarkets." June 2021.

3 Mark É. Czeisler et al. "Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020," Morbidity and Mortality Weekly Report, August 14, 2020; Volume 69, Number 32, pp. 1049–57,

Glen Akselrod
Bristol Investor Relations
T: (905) 326-1888 ext 1

News Provided by Business Wire via QuoteMedia

The Conversation (0)
Radiopharm Theranostics

Radiopharm Theranostics Limited (ASX: RAD) – Trading Halt


The securities of Radiopharm Theranostics Limited (‘RAD’) will be placed in trading halt at the request of RAD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 24 June 2024 or when the announcement is released to the market.

Keep reading...Show less
Man holds hand to head as fragments break off representing Alzheimer's disease.

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies in 2024

Alzheimer’s disease treatment stocks are focused on Alzheimer’s disease, a degenerative brain disorder that results in declining memory and thinking skills and typically affects people in their mid-60s.

According to the Alzheimer’s Association, neurons in other areas of the brain also begin to deteriorate as Alzheimer’s disease gets worse, resulting in the loss of basic human functions and overall cognitive impairment.

This condition affects more than 6.9 million people in the US alone; it’s also the most common form of dementia and is the seventh leading cause of death in America. Treatments are available to alleviate Alzheimer’s disease symptoms, but because they do not affect the underlying causes of this neurodegenerative disease, they’re only a bandaid solution.

Keep reading...Show less
GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report

GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report

Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare's newly published research report, "Novel Treatments for Age-Related Skin Problems." The report provides an in-depth analysis of the latest advancements in the $12.5 billion anti-aging skincare market.

The research highlights GlycoProteMim alongside other prominent active ingredients such as OneSkin's OS-01, Sisley Paris' Soy Peptides, SK-II's Pitera™, and SkinMedica's TNS Advanced Serum. GlycoProteMim is recognized for its unique approach to skin rejuvenation, addressing both surface-level appearance and underlying cellular mechanisms, making it a standout in the evolving landscape of skincare treatments.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations

Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations

Stonegate Healthcare Partners, a leading name in healthcare consultancy and market intelligence, is pleased to announce the publication of a comprehensive thematic report titled "Leading Innovations in Anti-Aging Dermatology." This report delves into the transformative advancements in the treatment of age-related skin conditions, focusing on cutting-edge technologies and personalized holistic approaches that are poised to revolutionize the skincare industry.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Emerging novel topicals: Innovations like OneSkin's OS-01, Sirona Biochem's GlycoProteMim, and SK-II's Pitera offer signficant benefits that will let them take market share away from existing treatments.
  • Personalized and holistic skincare: Advances ingenomics, skin diagnostics, and AI-driven tools enable tailored treatment plans ushering in a new era of skincare.
  • Companies highlighted in this report are: SkinMedica, SK-II, Sirona Biochem (TSXV: SBM), One Skin, and CTEK Sisley.

Cannot view this image? Visit:

Click image above to view full announcement.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less


BLINCYTO ® Added to Multiphase Consolidation Chemotherapy Reduced Risk of Death by 58% Showing Superior Overall Survival Versus Chemotherapy Alone

First and Only Bispecific T-cell Engager (BiTE ® ) Therapy for Consolidation Treatment Regardless of Measurable Residual Disease (MRD) Status

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
  BPH Global Ltd

Seaweed-Sourced Energy R&D Program Further Refined - Focus on Biohydrogen and Essential Mineral Extraction

The Board ofBPH Global Ltd (ASX: BP8) (Company) is pleased to announce that the Company has further reviewed and refined its R&D program, and in particular, its Seaweed-sourced energy R&D program.

Keep reading...Show less

Latest Press Releases

Related News